found
genom
rna
synthesi
inhibit
cycloheximid
cell
infect
mous
hepat
viru
strain
agreement
previous
publish
result
sawicki
sg
sawicki
dt
j
viral
present
studi
fate
residu
genom
rna
synthes
presenc
cycloheximid
determin
nearli
genom
rna
synthes
presenc
drug
incoor
nucleocapsid
structur
suggest
even
absenc
protein
synthesi
genom
rna
synthesi
encapsid
coupl
mhvinfect
cell
suffici
free
nucleocapsid
n
protein
avail
purpos
sinc
pool
solubl
n
protein
determin
decay
halflif
approxim
one
hour
neg
strand
rna
templat
synthesi
genom
subgenom
posit
strand
rna
would
predict
accumul
primarili
eariy
phase
iytic
cycl
agreement
predict
neg
strand
rna
accumul
first
h
infect
littl
addit
accumul
occur
next
h
mark
contrast
posit
strand
rna
increas
ifold
h
period
result
taken
conjunct
publish
data
suggest
neg
strand
rna
synthes
earli
period
infecti
cycl
stabl
infect
cell
also
suggest
treatment
cycloheximid
late
time
inhibit
posit
mous
hepat
viru
mhv
coronaviru
contain
polyadenyl
infecti
rna
genom
approxim
molecular
weight
x
leibowitz
et
al
siddel
et
al
spaan
et
al
intracellular
viral
rna
consist
nest
set
mrna
overlap
cheley
et
al
lai
et
al
leibowitz
et
al
siddel
et
al
spaan
et
al
largest
intracellular
viral
rna
correspond
length
genom
rna
call
rna
six
intracellular
rna
label
respect
largest
smallest
rna
rna
rna
base
sequenc
end
leader
rna
deriv
genom
lai
et
al
lai
et
al
spaan
et
al
spaan
et
al
viral
penetr
uncoat
first
step
replic
believ
translat
input
rna
rnadepend
rna
polymeras
polymeras
believ
catalyz
synthesi
complementari
copi
input
rna
neg
strand
serv
templat
synthesi
seven
posit
strand
mrna
previrion
rna
full
length
neg
strand
rna
detect
infect
cell
lai
et
al
presum
serv
templat
mrna
previrion
rna
neg
strand
rna
alway
contain
viral
replic
intermedi
synthes
maxim
rate
h
pi
tissu
cultur
cell
sawicki
sawicki
maxim
synthesi
genom
subgenom
rna
mhvinfect
cell
requir
continu
protein
synthesi
time
infect
brayton
et
al
mahi
et
al
sawicki
sawicki
report
show
residu
genom
rna
synthes
presenc
cycloheximid
incorpor
nucleocapsid
also
show
neg
strand
rna
accumul
primarili
first
hour
lytic
cycl
suggest
effect
cycloheximid
subgenom
genom
rna
synthesi
explain
lack
neg
strand
templat
weakli
hepatotrop
strain
adapt
tissu
cultur
cell
use
experi
kindli
provid
dr
weiss
viru
plaqu
purifi
twice
grown
monolay
cultur
mous
fibroblast
cell
dulbecco
mem
dmem
supplement
fetal
calf
serum
hepe
ph
h
viral
stock
prepar
supernat
titrat
cell
monolay
cultur
cell
grown
tissu
cultur
dish
infect
moi
adsorpt
min
dmem
supplement
fetal
calf
serum
hepe
ph
ad
dish
actinomycin
pgml
gift
merck
sharp
dohm
ad
plate
time
cell
label
uridin
cimm
amersham
corp
pciml
describ
figur
caption
label
cell
wash
cold
phosphatebuff
salin
pb
dislodg
dish
rubber
policeman
pellet
cell
lyse
ntm
nacl
tri
ph
mgcl
vanadyl
sulfateribonucleosid
complex
mm
final
concentr
ad
prior
use
berger
birkemei
found
viral
rna
particularli
rna
partial
degrad
complex
omit
lysi
buffer
cytoplasm
prepar
sodium
dodecyl
sulfat
sd
ad
rna
extract
phenol
contain
chloroform
rna
precipit
ethanol
rna
analyz
agaros
gel
electrophoresi
denatur
condit
formaldehyd
lehrach
et
al
rna
denatur
treatment
min
solut
contain
formaldehyd
formamid
mm
mop
ph
electrophoresi
complet
gel
treat
new
england
nuclear
corp
expos
kodak
xar
film
c
time
indic
figur
caption
vanadyl
sulfateribonucleosid
complex
cell
lyse
cytoplasm
prepar
edta
ad
final
concentr
sampl
layer
sucros
gradient
contain
rsb
mm
vanadyl
sulfateribonucleosid
complex
centrifug
rpm
beckman
rotor
time
indic
figur
caption
gradient
fraction
assay
tcaprecipit
radioact
unlabel
rna
isol
infect
cell
time
indic
prepar
either
dot
blot
analysi
describ
thoma
slot
blot
analysi
suggest
manufactur
schleicher
schuell
slot
blot
analysi
rna
treat
min
applic
nitrocellulos
paper
formaldehyd
x
ssc
x
ssc
nacl
na
citrat
nitrocellulos
bake
prehybrid
hybrid
describ
thoma
prehybrid
hybrid
perform
c
formamid
x
ssc
mm
phosphat
buffer
ph
pgml
denatur
sonic
calf
thymu
dna
sd
ficol
polyvinylpyrrolidon
bovin
serum
albumin
probe
use
analysi
bp
sequenc
mhvjhm
portion
genom
approxim
homolog
jhm
strain
skinner
siddel
virion
rna
origin
clone
standard
techniqu
maniati
et
al
phage
mess
phage
contain
posit
neg
strand
sequenc
select
anneal
dna
complementari
virion
rna
dna
isol
phenol
extract
label
describ
mess
briefli
ng
templat
ng
hybrid
probe
primer
base
primer
pl
biochem
anneal
togeth
min
h
buffer
mm
tri
ph
mm
nacl
mm
mgcl
mm
dithiothreitol
cool
dgtp
datp
ttp
final
concentr
pm
yci
dctp
cimm
amersham
corpor
u
dna
polymeras
klenow
fragment
boehringermannheim
biochem
ad
reaction
incub
min
termin
edta
label
dna
use
without
purif
condit
synthesi
dna
becom
doubl
strand
insert
portion
remain
singl
strand
final
specif
activ
x
dpmpg
anneal
blot
wash
describ
thoma
final
wash
x
ssc
mm
phosphat
buffer
sd
mm
edta
blot
expos
kodak
xar
describ
figur
legend
label
protein
four
dish
infect
cell
wash
methioninefre
dmem
supplement
dialyz
calf
serum
resuspend
medium
contain
pciml
methionin
min
one
sampl
immedi
harvest
unlabel
methionin
final
concentr
mm
ad
three
dish
sampl
incub
addit
min
harvest
cell
wash
icecold
pb
three
time
process
describ
prepar
nucleocapsid
experi
centrifug
rpm
h
beckman
rotor
order
pellet
nucleocapsid
gradient
fraction
sampl
assay
tcaprecipit
radioact
solubl
protein
present
top
two
fraction
gradient
concentr
centricon
microconcentr
amicon
nucleocapsid
protein
present
pellet
resuspend
nte
buffer
nacl
tri
ph
edta
contain
sd
portion
sampl
analyz
sdspolyacrylamid
gel
electrophoresi
previous
describ
laemmli
maizel
denison
perlman
autoradiograph
scan
shimadzu
dualwavelength
tlc
scanner
maxim
rna
synthesi
mhvinfect
cell
occur
h
pi
presenc
cycloheximid
inhibit
incorpor
uridin
viral
rna
time
infect
agreement
previou
report
brayton
et
al
mahi
et
al
sawicki
sawicki
also
confirm
result
sawicki
sawicki
show
synthes
genom
subgenom
rna
inhibit
cycloheximid
time
infect
although
found
synthesi
genom
rna
slightli
sensit
protein
synthesi
inhibit
subgenom
rna
thu
experi
shown
fig
lb
robb
bond
spaan
et
al
believ
precursor
infecti
viru
determin
effect
cycloheximid
synthesi
structur
cytoplasm
prepar
control
drugtreat
infect
cell
h
pi
divid
two
part
portion
sampl
assay
presenc
nucleocapsid
sucros
gradient
sediment
analysi
edtaresist
structur
sediment
isol
fig
shown
contain
rna
fig
lb
agreement
previou
report
spaan
et
al
pretreat
cycloheximid
caus
approxim
inhibit
appear
rna
nucleocapsid
structur
rna
extract
remaind
sampl
analyz
directli
gel
electrophoresi
fig
sinc
synthes
rna
viral
nucleocapsid
inhibit
nearli
extent
respect
suggest
residu
genom
rna
produc
presenc
cycloheximid
incorpor
nucleocapsid
determin
directli
genom
rna
synthes
treat
cell
present
nucleocapsid
ribonucleoprotein
particl
fraction
sucros
gradient
individu
fraction
assay
presenc
rna
shown
fig
rna
could
detect
nucleocapsid
slower
sediment
particl
result
indic
synthesi
previrion
rna
incorpor
nucleocapsid
structur
remain
coupl
presenc
cycloheximid
result
suggest
substanti
pool
free
nucleocapsid
n
protein
exist
infect
cell
measur
size
pool
cell
label
min
methionin
chase
variou
time
vast
excess
unlabel
methionin
increas
total
radioact
occur
initi
puls
period
prove
chase
effect
sampl
contain
solubl
nucleocapsid
protein
prepar
analyz
polyacrylamid
gel
elecfract
number
fig
effect
ciohexid
nucleocapsid
synthesi
cytoplasm
prepar
control
cyloexidetr
cell
label
udin
ciml
h
pi
min
sampl
split
one
portion
analyz
sucros
gradient
centrifug
min
pm
beckman
sw
rotor
describ
materi
method
gradient
fraction
ml
fraction
ml
remov
fraction
assay
tcaprecipit
radioact
top
gradient
right
l
control
cycloheximid
ad
min
prior
label
b
rna
extract
second
part
sampl
phenolchloroform
analyz
gel
electrophoresi
describ
materi
method
lane
control
lane
cycloheximidetr
h
exposur
lane
lane
expos
h
lane
nucleocapsid
structur
control
sampl
indic
fig
pool
deprotein
phenolchloroform
analyz
agaros
gel
electrophoresi
gel
expos
h
seven
intracellular
viral
rna
label
gel
trophoresi
describ
materi
method
fig
three
major
structur
protein
n
el
molecular
weight
respect
evid
solubl
fraction
min
label
absent
lysat
mockinfect
cell
protein
could
also
select
precipit
specif
antiserum
direct
viral
protein
data
shown
short
period
label
radioact
amino
acid
intracellular
pool
n
protein
mhvinfect
cell
shown
decreas
subsequ
min
chase
larg
excess
unlabel
amino
acid
anderson
et
al
siddel
et
al
sturman
holm
agreement
observ
found
approm
total
amount
n
protein
present
time
point
simplifi
analysi
min
puls
n
protein
present
solubl
fraction
nucleocapsid
fraction
fig
min
chase
n
protein
present
nearli
equal
amount
solubl
nucleocapsid
fraction
fig
experi
show
suffici
pool
free
n
protein
present
infect
cell
support
continu
incorpor
newli
synthes
rna
nucleocapsid
even
absenc
de
nova
protein
synthesi
especi
sinc
genom
rna
synthesi
reduc
condit
possibl
observ
inhibit
posit
strand
rna
synthesi
cycloheximid
might
partial
due
inhibit
synthesi
neg
molecular
weight
unlabel
marker
run
parallel
stain
coomassi
blue
also
indic
major
viral
protein
gel
expos
h
left
right
blot
expos
day
day
respect
strand
templat
thu
next
set
experi
measur
amount
posit
neg
strand
rna
present
infect
cell
prior
h
pi
begin
h
pi
end
h
pi
maxim
viral
rna
synthesi
purpos
clone
dna
probe
specif
posit
neg
strand
rna
sequenc
prepar
describ
materi
method
probe
anneal
unlabel
rna
isol
uninfect
infect
cell
fix
nitrocellulos
filter
fig
anneal
occur
rna
uninfect
cell
fig
expect
posit
strand
rna
accumul
throughout
infect
increas
approxim
h
h
pi
fig
hand
neg
strand
rna
present
low
quantiti
throughout
infect
although
could
detect
earli
h
pi
h
pi
neg
strand
rna
clearli
present
littl
addit
accumul
less
occur
h
pi
experi
estim
neg
strand
rna
repres
approxim
rna
h
pi
less
h
pi
conclud
inhibit
posit
strand
synthesi
cycloheximid
late
time
infect
like
due
lack
neg
strand
templat
inhibit
genom
subgenom
rna
synthesi
mhvinfect
cell
sawicki
sawicki
fig
genom
rna
synthes
presenc
cycloheximid
continu
incorpor
nucleocapsid
suggest
synthesi
genom
rna
encapsid
may
coupl
cell
infect
vesicular
stomat
viru
vsv
cycloheximid
caus
rapid
cessat
genom
rna
synthesi
perlman
huang
wertz
levin
ratelimit
protein
appear
nucleocapsid
n
protein
patton
et
al
vsvinfect
cell
n
protein
present
solubl
pool
min
label
decreas
min
chase
knipe
et
al
hsu
et
al
contrast
mhvinfect
cell
pool
free
n
protein
much
larger
sinc
n
protein
present
solubl
fraction
min
label
decreas
approxim
next
hour
thu
suffici
n
protein
exist
encapsid
genom
rna
synthes
presenc
cycloheximid
whether
n
protein
ratelimit
genom
rna
synthesi
mhvinfect
cell
remain
determin
cycloheximid
also
inhibit
subgenom
rna
synthesi
mhvinfect
cell
contrast
effect
transcript
cell
infect
virus
vsv
semliki
forest
viru
mrna
synthesi
declin
rather
remain
constant
absenc
protein
synthesi
perlman
huang
wertz
levin
sawicki
sawicki
synthesi
mhv
subgenom
rna
believ
includ
synthesi
leader
sequenc
turn
serv
primer
bodi
rna
spaan
et
al
lai
et
al
effect
cycloheximid
subgenom
rna
synthesi
may
reflect
labil
either
viral
polymeras
protein
involv
synthesi
process
leader
rna
similarli
effect
drug
genom
rna
synthesi
may
reflect
labil
one
protein
rather
limit
suppli
n
protein
sever
aspect
neg
strand
mhv
rna
synthesi
elucid
first
genomes
rna
polar
found
infect
cell
lai
et
al
second
neg
strand
rna
synthes
maxim
h
pi
sawicki
sawicki
chief
product
observ
viral
polymeras
activ
assay
h
pi
vitro
brayton
et
al
third
result
show
neg
strand
rna
accumul
primarili
earli
stage
infecti
cycl
result
togeth
suggest
neg
strand
rna
synthes
earli
time
infecti
cycl
stabl
speci
rna
infect
cell
result
also
suggest
cycloheximid
inhibit
posit
strand
rna
synthesi
indirectli
via
inhibit
neg
strand
synthesi
sinc
product
posit
strand
rna
remain
sensit
cycloheximid
time
synthesi
accumul
neg
strand
rna
minim
